# Vitalant Reference and Transfusion Service – FDA Inspection, Jun 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/9b51b005-e424-453b-95f5-36b629f591c4
Source feed: FDA_Inspections

> FDA inspection 1241647 of Vitalant Reference and Transfusion Service, June 13, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241647
- Company Name: Vitalant Reference and Transfusion Service
- Inspection Date: 2024-06-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1098877 - 2019-08-05](https://www.keypedia.com/records/fda_inspections/vitalant-reference-and-transfusion-service/b71aa00a-ccc5-427c-bb21-b6a3afa8e1ae)
- FDA Inspection 1019105 - 2017-07-17
- FDA Inspection 928230 - 2015-05-28
- FDA Inspection 817490 - 2013-02-07
- FDA Inspection 707706 - 2011-01-25

## Related Officers

- [Investigator](https://www.keypedia.com/people/carl-e-lovrich/28ad3898-eaac-4f07-8dc5-09bda890c63a)

Company: https://www.keypedia.com/companies/vitalant-reference-and-transfusion-service/1bc47b85-6833-4939-bd16-6dd050536dbf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
